Author/Authors :
Wang، نويسنده , , Jinghua and Zhang، نويسنده , , Xin and Mu، نويسنده , , Lili and Zhang، نويسنده , , Mingqing and Gao، نويسنده , , Zhongming and Zhang، نويسنده , , Jia and Yao، نويسنده , , Xiuhua and Liu، نويسنده , , Chuanliang and Wang، نويسنده , , Guangyou and Wang، نويسنده , , Dandan and Kong، نويسنده , , Qingfei and Liu، نويسنده , , Yumei and Li، نويسنده , , Na and Sun، نويسنده , , Bo and Li، نويسنده , , Hulun، نويسنده ,
Abstract :
In this study, the capacity for t-PA to affect T cell-brain microvascular endothelial cell adhesion by acting as a cytokine was investigated. Following the treatment of a brain-derived endothelial cell line, bEnd.3, with various concentrations of t-PA, adhesion and transwell migration assays were performed. In the presence of t-PA, enhanced adhesion of T cells to bEnd.3 cells was observed. Using western blot analysis, an increase in ICAM-1 expression was detected for both t-PA-treated bEnd.3 cells and bEnd.3 cells treated with a non-enzymatic form of t-PA. In contrast, when LRP1 was blocked using a specific antibody, upregulation of ICAM-1 was inhibited and cAMP–PKA signaling was affected. Furthermore, using an EAE mouse model, administration of t-PA was associated with an increase in ICAM-1 expression by brain endothelial cells. Taken together, these findings suggest that t-PA can induce ICAM-1 expression in brain microvascular endothelial cells, and this may promote the development of EAE.
Keywords :
Icam-1 , Endothelial cells , LRP1 , experimental autoimmune encephalomyelitis , tissue-type plasminogen activator